Systematic review with meta-analysis: Coffee consumption and the risk of gallstone disease

Alimentary Pharmacology and Therapeutics

Volumn 42, Issue 6, 2015, Pages 637-648

  Zhang, Y P ^a   Li, W Q ^a   Sun, Yu Ling ^a   Zhu, R T ^a   Wang, W J ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTECTOMY; COFFEE; DISEASE ASSOCIATION; ECHOGRAPHY; FOOD FREQUENCY QUESTIONNAIRE; GALLSTONE; HUMAN; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; CASE CONTROL STUDY; DOSE RESPONSE; FEMALE; GALLSTONES; MALE; META ANALYSIS; PROSPECTIVE STUDY; RISK;

COFFEE;

CASE-CONTROL STUDIES; COFFEE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GALLSTONES; HUMANS; MALE; PROSPECTIVE STUDIES; RISK; SEX FACTORS;

EID: 84939576160     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13328     Document Type: Review

References (47)

1. Douglas BR, Jansen JB, Tham RT, Lamers CB,. Coffee stimulation of cholecystokinin release and gallbladder contraction in humans. Am J Clin Nutr 1990; 52: 553-6.
2. Lillemoe KD, Magnuson TH, High RC, Peoples GE, Pitt HA,. Caffeine prevents cholesterol gallstone formation. Surgery 1989; 106: 400-6; discussion 406-7.
3. Leitzmann MF, Willett WC, Rimm EB, et al,. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA 1999; 281: 2106-12.
4. Leitzmann MF, Stampfer MJ, Willett WC, Spiegelman D, Colditz GA, Giovannucci EL,. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology 2002; 123: 1823-30.
5. Misciagna G, Leoci C, Guerra V, et al,. Epidemiology of cholelithiasis in southern Italy. Part II: Risk factors. Eur J Gastroenterol Hepatol 1996; 8: 585-93.
6. Nordenvall C, Oskarsson V, Wolk A,. Inverse association between coffee consumption and risk of cholecystectomy in women but not in men. Clin Gastroenterol Hepatol 2015; 13: 1096-1102.e1.
7. Pastides H, Tzonou A, Trichopoulos D, et al,. A case-control study of the relationship between smoking, diet, and gallbladder disease. Arch Intern Med 1990; 150: 1409-12.
8. Jorgensen T,. Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus. Gut 1989; 30: 528-34.
9. La Vecchia C, Negri E, D'Avanzo B, Franceschi S, Boyle P,. Risk factors for gallstone disease requiring surgery. Int J Epidemiol 1991; 20: 209-15.
10. Ishizuk H, Eguchi H, Oda T, et al,. Relation of coffee, green tea, and caffeine intake to gallstone disease in middle-aged Japanese men. Eur J Epidemiol 2003; 18: 401-5.
11. Volzke H, Baumeister SE, Alte D, et al,. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005; 71: 97-105.
12. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
13. Stang A,. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-5.
14. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
15. Hamling J, Lee P, Weitkunat R, Ambuhl M,. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008; 27: 954-70.
16. Greenland S, Longnecker MP,. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301-9.
17. Rong Y, Chen L, Zhu T, et al,. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. BMJ 2013; 346: e8539.
18. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D,. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012; 175: 66-73.
19. Desquilbet L, Mariotti F,. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010; 29: 1037-57.
20. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
21. Egger M, Davey SG, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
22. Sterne JA, Sutton AJ, Ioannidis JP, et al,. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343: d4002.
23. Sahi T, Paffenbarger RJ, Hsieh CC, Lee IM,. Body mass index, cigarette smoking, and other characteristics as predictors of self-reported, physician-diagnosed gallbladder disease in male college alumni. Am J Epidemiol 1998; 147: 644-51.
24. Jayanthi V, Anand L, Ashok L, Srinivasan V,. Dietary factors in pathogenesis of gallstone disease in southern India-a hospital-based case-control study. Indian J Gastroenterol 2005; 24: 97-9.
25. Chandran AP, Sivarajan RR, Srinivas M, Srinivasan V, Venkataraman J,. Risk factors for choledocholithiasis in a south Indian population: a case-control study. Indian J Gastroenterol 2013; 32: 381-5.
26. Chandran AP, Sivarajan R, Srinivasan V, Srinivas M, Jayanthi V,. Risk profile for gallstone disease in southern Indian population: is there anything new? Indian J Gastroenterol 2014; 33: 254-7.
27. Banim PJR, Luben R, Sharp SJ, Wareham NJ, Khaw KT, Hart AR,. The aetiology of gallstones-caffeinated coffee is associated with a reduction of symptomatic gallstones in men: data from a UK prospective cohort study (epic-norfolk) using 7-day food diaries. Gut 2011; 60: A224-5.
28. Ruhl CE, Everhart JE,. Association of coffee consumption with gallbladder disease. Am J Epidemiol 2000; 152: 1034-8.
29. Magnuson TH, Zarkin BA, Lillemoe KD, May CA, Bastidas JA, Pitt HA,. Caffeine inhibits gallbladder absorption. Curr Surg 1989; 46: 477-9.
30. Brown SR, Cann PA, Read NW,. Effect of coffee on distal colon function. Gut 1990; 31: 450-3.
31. Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J,. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol 2012; 47: 197-203.
32. Yesil A, Yilmaz Y,. Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013; 38: 1038-44.
33. Conter RL, Roslyn JJ, Porter-Fink V, DenBesten L,. Gallbladder absorption increases during early cholesterol gallstone formation. Am J Surg 1986; 151: 184-91.
34. Reymann A, Braun W, Drobik C, Woermann C,. Stimulation of bile acid active transport related to increased mucosal cyclic AMP content in rat ileum in vitro. Biochim Biophys Acta 1989; 1011: 158-64.
35. Botham KM, Suckling KE,. The effect of dibutyryl cyclic AMP on the excretion of taurocholic acid from isolated rat liver cells. Biochim Biophys Acta 1986; 889: 382-5.
36. Nagata C, Kabuto M, Shimizu H,. Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr Cancer 1998; 30: 21-4.
37. Bracco D, Ferrarra JM, Arnaud MJ, Jequier E, Schutz Y,. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol 1995; 269: E671-8.
38. Groisser DS,. A study of caffeine in tea. I. A new spectrophotometric micro-method. II. Concentration of caffeine in various strengths, brands, blends, and types of teas. Am J Clin Nutr 1978; 31: 1727-31.
39. Kato T, Takahashi S, Kikugawa K,. Loss of heterocyclic amine mutagens by insoluble hemicellulose fiber and high-molecular-weight soluble polyphenolics of coffee. Mutat Res 1991; 246: 169-78.
40. Gillies ME, Birkbeck JA,. Tea and coffee as sources of some minerals in the New Zealand diet. Am J Clin Nutr 1983; 38: 936-42.
41. Ortega RM, Fernandez-Azuela M, Encinas-Sotillos A, Andres P, Lopez-Sobaler AM,. Differences in diet and food habits between patients with gallstones and controls. J Am Coll Nutr 1997; 16: 88-95.
42. Aeschbacher HU,. Mutagenic and Antimutagenic Compounds in Beverages. Mutagens in Food: Detection and Prevention. Boca Raton, FL: CRC Press, 1991; 181-91.
43. Folstar P, van der Plas HC, Pilnik W, de Heus JG,. Tocopherols in the unsaponifiable matter of coffee bean oil. J Agric Food Chem 1977; 25: 283-5.
44. Devasagayam TP, Kamat JP, Mohan H, Kesavan PC,. Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species. Biochim Biophys Acta 1996; 1282: 63-70.
45. Eder MI, Miquel JF, Jongst D, Paumgartner G, von Ritter C,. Reactive oxygen metabolites promote cholesterol crystal formation in model bile: role of lipid peroxidation. Free Radic Biol Med 1996; 20: 743-9.
46. Ferraroni M, Tavani A, Decarli A, et al,. Reproducibility and validity of coffee and tea consumption in Italy. Eur J Clin Nutr 2004; 58: 674-80.
47. Attili AF, Carulli N, Roda E, et al,. Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.). Am J Epidemiol 1995; 141: 158-65.